Cholinesterase activity in brain of senescence-accelerated-resistant mouse SAMR1 and its variation in brain of senescence-accelerated-prone mouse SAMP8

Journal of Neuroscience Research

Volumn 88, Issue 1, 2010, Pages 155-166

  Fernández Gómez, Francisco José ^a,b   Muñoz Delgado, Encarnación ^b   Montenegro, María Fernanda ^b   Campoy, Francisco J ^b   Vidal, Cecilio J ^b   Jordán, Joaquín ^a  

^a UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^b UNIVERSITY OF MURCIA   (Spain)

Author keywords

Acetylcholinesterase; Butyrylcholinesterase; Cholinergic neurotransmission; Cognitive impairment; Gliosis

Indexed keywords

ACETYLCHOLINESTERASE; AMYLOID BETA PROTEIN; CHOLINESTERASE; DETERGENT; DIMER; GLIAL FIBRILLARY ACIDIC PROTEIN; LECTIN; MARKER; MESSENGER RNA; MONOMER; TETRAMER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; BRAIN CORTEX; BRAIN NERVE CELL; CHROMATOGRAPHY; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; ENZYME ACTIVITY; EXTRACT; GEL CHROMATOGRAPHY; GLIA CELL; GLIOSIS; LEARNING; MEMORY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENESCENCE ACCELERATED MOUSE; SPECIES;

AGING; ANIMALS; ASTROCYTES; BLOTTING, WESTERN; CEREBRUM; CHOLINESTERASES; FLUORESCENT ANTIBODY TECHNIQUE; GLIAL FIBRILLARY ACIDIC PROTEIN; IMAGE PROCESSING, COMPUTER-ASSISTED; LECTINS; MICE; MICE, INBRED STRAINS; MICROSCOPY, CONFOCAL; NEURONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 73949131047     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22177     Document Type: Article

References (65)

1. Arendt T, Brückner MK, Lange M, Bigl V. 1992. Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development. A study of molecular forms. Neurochem Int 21:381-396.
2. Banks WA, Robinson SM, Verma S, Morley JE. 2003. Efflux of human and mouse amyloid β proteins 1-40 and 1-42 from brain: impairment in a mouse model of Alzheimer's disease. Neuroscience 121:487-492.
3. Boncristiano S, Calhoun ME, Pfeifer M, Bondolfi L, Stalder M, Phinney AL, Abramoski D, Sturchler-Pierrat C, Enz A, Sommer B, Staunfenbiel M, Jucker M. 2002. Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis. J Neurosci 22:3234-3243.
4. Butterfield DA, Poon HF. 2005. The senescence-accelerated prone mouse (SAMP8): a model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer's disease. Exp Gerontol 40:774-783.
5. Cabezas-Herrera J, Moral-Naranjo MT, Campoy FJ, Vidal CJ. 1997. Glycosylation of acetylcholinesterase forms in microsomal membranes from normal and dystrophic Lama2dy mouse muscle. J Neurochem 69:1964-1974.
6. Chatel JM, Eichler J, Vallette FM, Bon S, Massolié J, Grassi J. 1994. Two-site immunoradiometric assay of chicken acetylcholinesterase: active and inactive molecular forms in brain and muscle. J Neurochem 63:1111-1118.
7. Cheng XR, Zhou WX, Zhang YX, Zhou DS, Yang RF, Chen LF. 2007. Differential gene expression profiles in the hippocampus of senescence- accelerated mouse. Neurobiol Aging 28:497-506.
8. Combarros O, Riancho JA, Arozamena J, Mateo I, Llorca J, Infante J, Sánchez-Juan P, Zarrabeitia MT, Berciano J. 2007. Interaction between estrogen receptor-α and butyrylcholinesterase genes modulates Alzheimer's disease risk. J Neurol 254:1290-1292.
9. Correa-Cerro LS, Mandell JW. 2007. Molecular mechanisms of astrogliosis. J Neuropathol Exp Neurol 66:169-176.
10. Darreh-Shori T, Brimijoin S, Kadir A, Almkvist O, Nordberg A. 2006. Differential CSF butyrylcholinesterase levels in Alzheimer's disease with the ApoE-ε4 allele, in relation to cognitive function and cerebral glucose metabolism. Neurobiol Dis 24:326-333.
11. Darvesh S, Hopkins DA, Geula C. 2003. Neurobiology of butyrylcholinesterase. Nat Neurosci 4:131-138.
12. Del Valle J, Duran-Vilaregut J, Manich G, Camins A, Pallas M, Vilaplana J, Pelegri C. 2009. Time-course of blood-brain barrier disruption in senescence-accelerated mouse prone 8 (SAMP8) mice. Int J Dev Neurosci 27:47-52.
13. Diamant S, Podoly E, Friedler A, Ligumsky H, Livnah O, Soreq H. 2006. Butyrylcholinesterase attenuates amyloid fibril formation in vitro. Proc Natl Acad Sci U S A 103:8628-8633.
14. Dumont M, Lalonde R, Ghersi-Egea JF, Fukuchi K, Strazielle C. 2006. Regional acetylcholinesterase activity and its correlation with behavioral performance in 15-month old transgenic mice expressing the human C99 fragment of APP. J Neural Transm 113:1225-1241.
15. Finch CE. 2003. Neurons, glia, and plasticity in normal brain aging. Neurobiol Aging 24:S123-S127.
16. Fodero LR, Sáez-Valero J, McLean CA, Martins RN, Beyreuther K, Masters CL, Robertson TA, Small DH. 2002. Altered glycosylation of acetylcholinesterase in APP (SW) Tg2576 transgenic mice occurs prior to amyloid plaque deposition. J Neurochem 81:441-448.
17. Fu AL, Zhang XM, Sun MJ. 2005. Antisense inhibition of acetylcholinesterase gene expression for treating cognition deficit in Alzheimer's disease model mice. Brain Res 1066:10-15.
18. García-Ayllón MS, Gómez JL, Vidal CJ. 1999. Amphiphilic properties of acetylcholinesterase monomers in mouse plasma. Neurosci Lett 265:211-214.
19. García-Ayllón MS, Sáez-Valero J, Muñoz-Delgado E, Vidal CJ. 2001. Identification of hybrid cholinesterase forms consisting of acetyl- and butyrylcholinesterase subunits in human glioma. Neuroscience 107:199-208.
20. Geula C, Nagykery N. 2007. Butyrylcholinesterase activity in the rat forebrain and upper brainstem: postnatal development and adult distribution. Exp Neurol 204:640-657.
21. Giacobini E. 2004. Cholinesterase inhibitors: new roles and therapeutic alternatives. Pharmacol Res 50:433-440.
22. Gilgun-Sherki Y, Melamed E, Offen D. 2006. Anti-inflammatory drugs in the treatment of neurodegenerative diseases: current state. Curr Pharm Des 12:3509-3519.
23. Greig NH, Utsuki T, Ingram DK, Wang Y, Pepeu G, Scali C, Yu QS, Mamczarz J, Holloway HW, Giordano T, Furukawa K, Sambamurti K, Brossi A, Lahiri DK. 2005. Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent. Proc Natl Acad Sci U S A 102:17213-17218.
24. Kabuto H, Yokoi I, Mori A, Murakami M, Sawada S. 1995. Neurochemical changes related to ageing in the senescence-accelerated mouse brain and the effect of chronic administration of nimodipine. Mech Ageing Dev 80:1-9.
25. Kim SU, de Vellis J. 2005. Microglia in health and disease. J Neurosci Res 81:302-323.
26. Kuhl DE, Koeppe RA, Snyder SE, Minoshima S, Frey KA, Kilbourn MR. 2006. In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapse. Ann Neurol 59:13-20.
27. Kuljis RO, Darvesh S, Greig NH, Geula C. 2006. Tomographic visualization of cholinesterase. Ann Neurol 60:745-746.
28. Li B, Stribley JA, Ticu A, Xie W, Schopfer LM, Hammond P, Brimijoin S, Hinrichs SH, Lockridge O. 2000. Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse. J Neurochem 75:1320-1331.
29. Lloréns S, de Mera RM, Prieto-Martin A, Mendizábal Y, de Cabo C, Nava E, Jordán J. 2007. The senescence-accelerated mouse (SAMP-8) as a model of vascular functional alterations during aging. Biogerontology 8:663-672.
30. Mack A, Robitzki A. 2000. The key role of butyrylcholinesterase during neurogenesis and neural disorders: an antisense-5′-butyrylcholinesterase- DNA study. Prog Neurobiol 60:607-628.
31. Massoulié J, Bon S, Perrier N, Falasca C. 2005. The C-terminal peptides of acetylcholinesterase: cellular trafficking, oligomerization and functional anchoring. Chem-Biol Interact 157-158:3-14.
32. Meshorer E, Soreq H. 2006. Virtues and woes of AChE alternative splicing in stress-related neuropathologies. Trends Neurosci 29:216-224.
33. Meshorer E, Toiber D, Zurel D, Sahly I, Dori A, Cagnano E, Schreiber L, Grisaru D, Tronche F, Soreq H. 2004. Combinatorial complexity of 5′ alternative acetylcholinesterase transcripts and protein products. J Biol Chem 279:29740-29751.
34. Mikami LR, Wieseler S, Souza RL, Schopfer LM, Lockridge O, Chautard-Freire-Maia EA. 2007. Expression of three naturally occurring genetic variants (G75R, E90D, I99M) of the BCHE gene of human butyrylcholinesterase. Pharmacogenet Genomics 17:681-685.
35. Mitrovic B, Ignarro LJ, Montestruque S, Smoll A, Merril JE. 1994. Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro. Neuroscience 61:575-585.
36. Miyamoto M, Kiyota Y, Nagaoka A, Matsuo Y, Takeda T. 1986. Age-related changes in learning and memory in the senescence-accelerated mouse (SAM). Physiol Behav 38:406.
37. Monsigny M, Sene C, Obrenovitch A, Roche AC, Delmotte F, Boschetti E. 1979. Properties of succinylated wheat-germ agglutinin. Eur J Biochem 98:39-45.
38. Montenegro MF, Ruiz-Espejo F, Campoy FJ, Muñoz-Delgado E, Páez de la Cadena M, Rodríguez-Berrocal FJ, Vidal CJ. 2006. Cholinesterases are down-expressed in human colorectal carcinoma. Cell Mol Life Sci 63:2175-2182.
39. Moral-Naranjo MT, Cabezas-Herrera J, Vidal CJ. 1996. Molecular forms of acetyl- and butyrylcholinesterase in normal and dystrophic mouse brain. J Neurosci Res 43:224-234.
40. Moral-Naranjo MT, Cabezas-Herrera J, Vidal CJ, Campoy FJ. 2002. Muscular dystrophy with laminin deficiency decreases the content of butyrylcholinesterase tetramers in sciatic nerves of Lama2dy mice. Neurosci Lett 331:155-158.
41. Morley JE, Farr SA, Kumar VB, Banks WA. 2002. Alzheimer's disease through the eye of a mouse: acceptance lecture for the 2001 Gayle A. Olson and Richard D. Olson prize. Peptides 23:589-599.
42. Nieto-Cerón S, Sánchez del Campo LF, Muñoz-Delgado E, Vidal CJ, Campoy FJ. 2005. Muscular dystrophy by merosin deficiency decreases acetylcholinesterase activity in thymus of Lama2dy mice. J Neurochem 95:1035-1046.
43. Nonaka N, Banks WA, Mizushima H, Shioda S, Morley JE. 2002. Regional differences in PACAP transport across the blood-brain barrier in mice: a possible influence of strain, amyloid β-protein, and age. Peptides 23:2197-2202.
44. Okuma Y, Nomura Y. 1998. Senescence-accelerated mouse (SAM) as an animal model of senile dementia: pharmacological, neurochemical and molecular biology approach. Jpn J Pharmacol 78:399-404.
45. Perrier NA, Kherif S, Perrier AL, Dumas S, Mallet J, Massoulie J. 2003. Expression of PRiMA in the mouse brain: membrane anchoring and accumulation of "tailed" acetylcholinesterase. Eur J Neurosci 18:1837-1847.
46. Podoly E, Bruck T, Diamant S, Melamed-Book N, Weiss A, Huang Y, Livnah O, Langermann S, Wilgus H, Soreq H. 2008. Human recombinant butyrylcholinesterase purified from the milk of transgenic goats interacts with beta-amyloid fibrils and suppresses their formation in vitro. Neurodegen Dis 5:232-236.
47. Poon HF, Castegna A, Farr SA, Thongboonkerd V, Lynn BC, Banks WA, Morley JE, Klein JB, Butterfield DA. 2004. Quantitative proteomics analysis of specific protein expression and oxidative modification in aged senescence-accelerated- prone 8 mice brain. Neuroscience 126:915-926.
48. Sage HJ, Green RW. 1972. Purification and properties of carbohydrate-binding proteins. Common lentil (Lens culinaris) phytohemagglutinin. Methods Enzymol 28:332-339.
49. Sáez-Valero J, Poza-Cisneros G, Vidal CJ. 1996. Molecular forms of acetyl- and butyrylcholinesterase in human glioma. Neurosci Lett 206:173-176.
50. Sáez-Valero J, Sberna G, McLean CA, Small DH. 1999. Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease. J Neurochem 72:1600-1608.
51. Sánchez del Campo LF, Nieto-Cerón S, Morote-García JC, Muñoz-Delgado E, Vidal CJ, Campoy FJ. 2007. Butyrylcholinesterase activity and molecular components in thymus of healthy and merosin-deficient Lama2dy mice. Neurochem Int 50:531-539.
52. Sberna G, Sáez-Valero J, Li QX, Czech C, Beyreuther K, Masters CL, McLean CA, Small DH. 1998. Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the beta-amyloid precursor of Alzheimer's disease. J Neurochem 71:723-731.
53. Shen ZX. 2004. Brain cholinesterases: I. The clinico-histopathological basis of Alzheimer's disease. Med Hypoth 63:285-297.
54. Shibuya N, Goldstein IJ, Broekaert WF, Nsimba-Lubaki M, Peeters B, Peumans WJ. 1987. The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac(α2-6)Gal/GalNAc sequence. J Biol Chem 262:1596-1601.
55. Silveyra MX, Evin G, Montenegro MF, Vidal CJ, Martínez S, Culvenor JG, Sáez-Valero J. 2008. Presenilin-1 interacts with acetylcholinesterase and alters its enzymatic activity and glycosylation. Mol Cell Biol 28:2908-2919.
56. Sirvio J, Soininen HS, Kutvonen R, Hyttinen JM, Helkala EL, Riekkinen PJ. 1987. Acetyl- and butyrylcholinesterase activity in the cerebrospinal fluid of patients with Parkinson's disease. J Neurol Sci 81:273-279.
57. Strong R, Reddy V, Morley JE. 2003. Cholinergic deficit in the septal-hippocampal pathway of the SAM-P/8 senescence accelerated mouse. Brain Res 966:150-156.
58. Takeda T. 2009. Senescence-accelerated mouse (SAM) with special references to neurodegeneration models, SAMP8 and SAMP10 mice. Neurochem Res 34:639-659.
59. Takeda T, Hosokawa M, Higuchi K. 1997. Senescence-accelerated mouse (SAM): a novel murine model of senescence. Exp Gerontol 32:105-109.
60. Tanaka J, Okuma Y, Tomobe K, Nomura Y. 2005. The age-related degeneration of oligodendrocytes in the hippocampus of the senescence-accelerated mouse (SAM) P8. A quantitative immunohistochemical study. Biol Pharm Bull 24:615-618.
61. Tha KK, Okuma Y, Miyazaki H, Murayama T, Uehara T, Hatakeyama R, Hayashi Y, Nomura Y. 2000. Changes in expressions of proinflammatory cytokines IL-1β, TNF-α and IL-6 in the brain of senescence accelerated mouse (SAM) P8. Brain Res 885:25-31.
62. Toiber D, Berson A, Greenberg D, Melamed-Book N, Diamant S, Soreq H. 2008. N-acetylcholinesterase-induced apoptosis in Alzheimer's disease. PLoS ONE 3:e3108.
63. Tornel PL, Sáez-Valero J, Vidal CJ. 1992. Ricinus communis agglutinin I reacting and nonreacting butyrylcholinesterase in human cerebrospinal fluid. Neurosci Lett 145:59-62.
64. Weikert T, Ebert C, Rasched I, Layer PG. 1994. Novel inactive and distinctively glycosylated forms of butyrylcholinesterase from chicken serum. J Neurochem 63:318-325.
65. Wu Y, Zhang AQ, Yew DT. 2005. Age related changes of various markers of astrocytes in senescence-accelerated mice hippocampus. Neurochem Int 46:565-574.